198 related articles for article (PubMed ID: 37965793)
61. Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection.
Burlando M; Russo R; Cozzani E; Parodi A
Dermatol Ther; 2021 Jan; 34(1):e14641. PubMed ID: 33278049
[TBL] [Abstract][Full Text] [Related]
62. Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review.
Cestari SDCP; Cestari MDCP; Marques GF; Lirio I; Tovo R; Cruz Silva Labriola I
An Bras Dermatol; 2023; 98(4):466-471. PubMed ID: 36964106
[TBL] [Abstract][Full Text] [Related]
63. [Cutaneous lesions in COVID-19 patients].
Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
[TBL] [Abstract][Full Text] [Related]
64. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.
Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Desai SR; Harp J; Takeshita J; French LE; Lim HW; Thiers BH; Hruza GJ; Fox LP
J Am Acad Dermatol; 2020 Oct; 83(4):1118-1129. PubMed ID: 32622888
[TBL] [Abstract][Full Text] [Related]
65. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19.
Gallizzi R; Sutera D; Spagnolo A; Bagnato AM; Cannavò SP; Grasso L; Guarneri C; Nunnari G; Mazza F; Pajno GB
Dermatol Ther; 2020 Nov; 33(6):e14312. PubMed ID: 32949449
[TBL] [Abstract][Full Text] [Related]
66. COVID-19 Skin Manifestations in Skin of Colour.
Akuffo-Addo E; Nicholas MN; Joseph M
J Cutan Med Surg; 2022; 26(2):189-197. PubMed ID: 34663122
[TBL] [Abstract][Full Text] [Related]
67. Skin lesions in children during the first wave of the SARS-CoV-2 pandemic.
Carazo Gallego B; Martín Pedraz L; Galindo Zavala R; Rivera Cuello M; Mediavilla Gradolph C; Núñez Cuadros E
Med Clin (Barc); 2021 Jul; 157(1):33-37. PubMed ID: 34016448
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns.
Rongioletti F; Ferreli C; Sena P; Caputo V; Atzori L
Clin Dermatol; 2021; 39(1):149-162. PubMed ID: 33972045
[TBL] [Abstract][Full Text] [Related]
69. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
[TBL] [Abstract][Full Text] [Related]
70. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
Li H; Zhao Y; Zhou L
Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
[TBL] [Abstract][Full Text] [Related]
71. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
[TBL] [Abstract][Full Text] [Related]
72. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
[TBL] [Abstract][Full Text] [Related]
73. Cutaneous Manifestations of Coronavirus Disease 2019: Skin Narratives and Dialogues.
Mohammed GF; Al-Dhubaibi MS; Atef L
J Clin Aesthet Dermatol; 2022 May; 15(5):E77-E81. PubMed ID: 35642227
[TBL] [Abstract][Full Text] [Related]
74. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
[TBL] [Abstract][Full Text] [Related]
75. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
Criado PR; Abdalla BMZ; de Assis IC; van Blarcum de Graaff Mello C; Caputo GC; Vieira IC
Inflamm Res; 2020 Aug; 69(8):745-756. PubMed ID: 32488318
[TBL] [Abstract][Full Text] [Related]
76. Mucocutaneous lesions associated with SARS-CoV-2 infection (Review).
Toader MP; Branisteanu DC; Glod M; Esanu IM; Branisteanu CI; Capsa MS; Dimitriu A; Nicolescu AC; Pinzariu AC; Branisteanu DE
Exp Ther Med; 2022 Apr; 23(4):258. PubMed ID: 35251324
[TBL] [Abstract][Full Text] [Related]
77. Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents.
Franulić D; Parać E; Dolački L; Topalušić I; Lugović-Mihić L
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):173-181. PubMed ID: 38126100
[TBL] [Abstract][Full Text] [Related]
78. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
Rajan M B; Kumar-M P; Bhardwaj A
Int J Dermatol; 2020 Nov; 59(11):1358-1370. PubMed ID: 32936462
[TBL] [Abstract][Full Text] [Related]
79. The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection.
Zaborska M; Chruszcz M; Sadowski J; Klaudel T; Pelczarski M; Sztangreciak-Lehun A; Bułdak RJ
Arch Dermatol Res; 2024 May; 316(6):292. PubMed ID: 38819524
[TBL] [Abstract][Full Text] [Related]
80. Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data.
Lee DS; Mirmirani P; McCleskey PE; Mehrpouya M; Gorouhi F
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
